Calyxo specializes in kidney stone care, with a focus on innovative medical devices and procedures, self-described as revolutionizing the field with the CVAC® System and the SURE Procedure.

Calyxo

Calyxo, Inc. | 10,632 followers on LinkedIn. Introducing CVAC System: A Revolution in Kidney Stone Care | Calyxo, Inc. is an innovation-driven medical device company focused on improving care for patients with kidney stones, a common and painful condition that consumes vast amounts of healthcare resources today.  Founded in 2016, Calyxo is led by executives and investors with a strong track record of commercializing paradigm-shifting solutions in the field of urology.  Our team features some of the most talented, high-achieving and brightest minds in the medical device industry who are compelled by a desire to make a difference in kidney stone care.

Senior Business Executive (SVP, COO)

Eric Steuben

Somaly Hoy

Director, Business Intelligence at Calyxo

Mark Petroni

Brett Erickson

Calyxo, Inc.

Attending the LUGPA Annual Meeting #LUGPA2024 ? Join us in Chicago to explore the latest advancements in kidney stone treatment with the CVAC System! 📅 November 14-16, 2024 📍 Chicago, IL 🏢 Booth #612 #Urology

Attending Connecticut Society of Urology Annual Educational Meeting? Join us in Plantsville, CT to explore the latest advancements in kidney stone treatment with the CVAC System! 📅 November 13, 2024 📍 Aqua Turf Club, Plantsville, CT #Urology

Missed the South-Central AUA Section #SCAUA2024 ? You can still request a live CVAC System demo for your practice from a Calyxo representative. 📧 About CVAC System: https://lnkd.in/gGX4EyAK Safety Info: https://calyxoinc.com/isi/

👏 Congratulations to Dr. Mark Saslawsky for being the first in Memphis to offer the SURE (Steerable Ureteroscopic Renal Evacuation) procedure with the CVAC System to treat their kidney stone patients! Dr. Saslawsky achieved >90% stone clearance for a 2 cm stone—an incredible milestone for the community and #Urology practice! Learn more about #CalyxoCVAC : https://lnkd.in/gGX4EyAK Safety Info: https://calyxoinc.com/isi/ #NoStoneLeftBehind #Urology #KidneyStoneTreatment

Happy Halloween! We’re here at #SCAUA2024 ! 👋 Come visit us to learn more about the CVAC System and how it's revolutionizing kidney stone treatment. #NoStoneLeftBehind #Urology #CalyxoCVAC

Attending the 2024 Western Section of the AUA (WSAUA)? Join us in Kauai to discover the latest advancements in kidney stone treatment with the CVAC System! 📅 October 27 - November 1, 2024 📍 Grand Hyatt Kauai, Hawaii Register now: https://surgewest.org/ #WSAUA #WSAUA2024 #Urology #KidneyStones

👏 Congratulations to Dr. Frank Lai for completing the first community hospital-based CVAC System procedure in Northern California. Dr. Lai successfully treated a patient with 7 stones, with a total 3 cm stone burden. The procedure performed at El Camino Health achieved a 100% stone-free outcome, demonstrating the effectiveness of the CVAC System in delivering exceptional patient outcomes. Learn more about #CalyxoCVAC : https://lnkd.in/gGX4EyAK Safety Info: https://calyxoinc.com/isi/ #NoStoneLeftBehind #Urology

The CVAC System uses simultaneous irrigation and vacuum aspiration to continuously clear stone fragments during and after laser lithotripsy, enabling physicians to achieve a stone-free outcome. 🎥Watch how it works: https://lnkd.in/gGX4EyAK Safety Info: https://calyxoinc.com/isi/ #NoStoneLeftBehind #Urology

👏 Congratulations to Dr. John Kaspar in Raleigh, NC, for performing his first CVAC System procedure! Achieving a remarkable 97% stone-free outcome for a 20 mm stone, Dr. Kaspar is setting new standards in kidney stone treatment. Learn more about #CalyxoCVAC : https://lnkd.in/gGX4EyAK Safety Info: https://calyxoinc.com/isi/ #NoStoneLeftBehind #Urology #KidneyStoneTreatment

Metric
Company Name	Calyxo
Symbol
MSH ID	COM:CALYXOINC
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices
Country	US
Stage	Series D
Employee Count
Website	calyxoinc.com
LinkedIn	calyxo
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	341
Web Traffic Growth	-0.23
Valuation
Raised Capital	50M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CALY

COM:CALYXOINC

Calyxo

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue